Table 2.
Adjusted one year survival and change in net survival for men with a diagnosis of one of 20 cancers between 1996 and 2013
Malignancy | 1996 | 2001 | 2006 | 2013 | 1996-2013 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Survival in most affluent (95% CI) | Deprivation gap (95% CI) | Survival in most affluent (95% CI) | Deprivation gap (95% CI) | Survival in most affluent (95% CI) | Deprivation gap (95% CI) | Survival in most affluent (95% CI) | Deprivation gap (95% CI) | Change in deprivation gap (%) | ||||||
Oesophagus | 32.4 (31.4 to 33.3) | −7.3 (−8.4 to −6.3) | 38.6 (37.9 to 39.3) | −7.3 (−8.4 to −6.3) | 44.8 (44.0 to 45.7) | −7.3 (−8.4 to −6.3) | 50.6 (49.5 to 51.7) | −7.3 (−8.4 to −6.3) | 0.0 | |||||
Stomach | 37.8 (36.8 to 38.9) | −5.8 (−7.1 to −4.6) | 42.1 (41.3 to 42.9) | −5.8 (−7.1 to −4.6) | 46.4 (45.6 to 47.1) | −5.8 (−7.1 to −4.6) | 52.4 (51.3 to 53.4) | −5.8 (−7.1 to −4.6) | 0.0 | |||||
Colon | 71.0 (70.1 to 72.0) | −7.9 (−9.2 to −6.5) | 73.5 (72.9 to 74.1) | −7.4 (−8.3 to −6.5) | 76.0 (75.3 to 76.7) | −7.0 (−7.7 to −6.2) | 81.6 (80.6 to 82.5) | −6.3 (−7.7 to −5.0) | 1.6 | |||||
Rectum | 77.9 (77.0 to 78.8) | −9.4 (−10.7 to −8.0) | 80.0 (79.5 to 80.6) | −8.9 (−9.8 to −8.0) | 82.2 (81.5 to 82.8) | −8.5 (−9.2 to −7.7) | 87.7 (86.8 to 88.7) | −7.8 (−9.2 to −6.5) | 1.6 | |||||
Liver | 21.5 (20.1 to 22.9) | −5.7 (−7.4 to −3.9) | 26.8 (25.6 to 27.9) | −5.7 (−7.4 to −3.9) | 32.0 (31.0 to 33.1) | −5.7 (−7.4 to −3.9) | 39.4 (38.0 to 40.8) | −5.7 (−7.4 to −3.9) | 0.0 | |||||
Pancreas | 16.2 (15.1 to 17.2) | −5.9 (−7.1 to −4.7) | 19.5 (18.7 to 20.3) | −5.9 (−7.1 to −4.7) | 22.8 (22.0 to 23.5) | −5.9 (−7.1 to −4.7) | 27.4 (26.3 to 28.4) | −5.9 (−7.1 to −4.7) | 0.0 | |||||
Larynx | 85.9 (84.7 to 87.1) | −6.3 (−7.8 to −4.9) | 86.5 (85.6 to 87.5) | −6.3 (−7.8 to −4.9) | 87.2 (86.4 to 88.1) | −6.3 (−7.8 to −4.9) | 88.2 (87.0 to 89.4) | −6.3 (−7.8 to −4.9) | 0.0 | |||||
Lung | 25.9 (25.2 to 26.7) | −4.0 (−4.7 to −3.2) | 28.6 (28.1 to 29.1) | −4.0 (−4.7 to −3.2) | 31.3 (30.6 to 32.0) | −4.0 (−4.7 to −3.2) | 38.6 (37.7 to 39.4) | −4.0 (−4.7 to −3.2) | 0.0 | |||||
Mesothelioma | 29.7 (27.6 to 31.9) | −2.9 (−4.7 to −1.0) | 30.9 (29.3 to 32.5) | −2.9 (−4.7 to −1.0) | 37.1 (36 to 38.3) | −2.9 (−4.7 to −1.0) | 45.9 (44.2 to 47.6) | −2.9 (−4.7 to −1.0) | 0.0 | |||||
Melanoma | 94.8 (93.9 to 95.6) | −6.2 (−7.6 to −4.8) | 95.6 (95.0 to 96.1) | −5.2 (−6.0 to −4.3) | 96.4 (95.9 to 96.9) | −4.1 (−4.9 to −3.4) | 97.5 (96.6 to 98.3) | −2.7 (−4.1 to −1.3) | 3.5 | |||||
Prostate | 83.6 (82.8 to 84.4) | −4.6 (−5.7 to −3.6) | 89.0 (88.5 to 89.6) | −3.7 (−4.3 to −3.0) | 89.1 (88.6 to 89.6) | −2.7 (−3.3 to −2.1) | 92.8 (92.1 to 93.5) | −1.4 (−2.4 to −0.3) | 3.2 | |||||
Testis | 97.3 (95.9 to 98.8) | −2.8 (−4.5 to −1.1) | 97.5 (96.4 to 98.7) | −2.8 (−4.5 to −1.1) | 97.7 (96.7 to 98.8) | −2.8 (−4.5 to −1.1) | 98.0 (96.5 to 99.4) | −2.8 (−4.5 to −1.1) | 0.0 | |||||
Bladder | 85.6 (84.6 to 86.6) | −5.8 (−6.6 to −4.9) | 81.7 (80.9 to 82.5) | −5.8 (−6.6 to −4.9) | 80.9 (80.1 to 81.7) | −5.8 (−6.6 to −4.9) | 83.0 (82.1 to 83.9) | −5.8 (−6.6 to −4.9) | 0.0 | |||||
Kidney | 64.1 (62.9 to 65.3) | −6.3 (−7.6 to −5.1) | 67.3 (66.5 to 68.1) | −6.3 (−7.6 to −5.1) | 70.5 (69.5 to 71.6) | −6.3 (−7.6 to −5.1) | 80.7 (79.4 to 82.0) | −6.3 (−7.6 to −5.1) | 0.0 | |||||
Brain | 35.9 (34.1 to 37.7) | −2.4 (−4.9 to 0.1) | 37.4 (36.2 to 38.6) | −3.9 (−5.5 to −2.3) | 43.8 (43.0 to 44.7) | −5.4 (−6.7 to −4.0) | 52.8 (51.2 to 54.4) | −7.5 (−10.0 to −5.0) | −5.1 | |||||
Thyroid | 84.4 (82.1 to 86.7) | −2.7 (−5.1 to −0.3) | 84.6 (83.1 to 86.2) | −2.7 (−5.1 to −0.3) | 84.9 (82.8 to 86.9) | −2.7 (−5.1 to −0.3) | 92.3 (89.8 to 94.8) | −2.7 (−5.1 to −0.3) | 0.0 | |||||
Non-Hodgkin lymphoma | 67.4 (66.2 to 68.5) | −8.2 (−9.9 to −6.4) | 71.6 (70.9 to 72.4) | −7.8 (−8.9 to −6.7) | 75.9 (75.2 to 76.6) | −7.4 (−8.4 to −6.5) | 81.9 (80.8 to 83.0) | −6.9 (−8.6 to −5.1) | 1.3 | |||||
Hodgkin lymphoma | 90.4 (88.3 to 92.5) | −5.1 (−8.3 to −2.0) | 89.0 (87.8 to 90.3) | −4.0 (−6.1 to −2.0) | 87.6 (86.2 to 89.1) | −3.0 (−4.7 to −1.2) | 90.0 (87.8 to 92.1) | −1.4 (−4.6 to 1.7) | 3.7 | |||||
Myeloma | 65.9 (64.6 to 67.2) | −5.6 (−7.0 to −4.3) | 69.7 (68.8 to 70.6) | −5.6 (−7.0 to −4.3) | 73.4 (72.3 to 74.6) | −5.6 (−7.0 to −4.3) | 86.7 (85.3 to 88.2) | −5.6 (−7.0 to −4.3) | 0.0 | |||||
Leukaemia | 65.1 (64.0 to 66.2) | −5.3 (−6.4 to −4.2) | 66.6 (65.9 to 67.4) | −5.3 (−6.4 to −4.2) | 68.2 (67.2 to 69.1) | −5.3 (−6.4 to −4.2) | 75.2 (74.0 to 76.4) | −5.3 (−6.4 to −4.2) | 0.0 |